原发性肝癌诊疗指南（2024年版）

Guidelines for the diagnosis and treatment of primary liver cancer (2024 edition)

摘要:

2024年4月，《原发性肝癌诊疗指南（2024年版）》正式发布。该指南是在国家卫生健康委医政司领导下，在《原发性肝癌诊疗指南》编写专家委员会、国家癌症中心、国家肿瘤质控中心肝癌质控专家委员会指导下，由全国肝癌领域各学科专家学者共同参与制定。《原发性肝癌诊疗指南（2024年版）》更新的内容主要包括：外科治疗方法及理念更新；局部消融价值的客观评价；血管内介入治疗焕发新生；放射治疗进一步探索优化；系统治疗的重大突破。作为原发性肝癌的规范性指导文件，该指南与时俱进，及时反映了肝癌诊疗领域的新进展与新理念，将有力推动中国肝癌规范化诊疗水平的提升，提升我国该领域在学术界的影响力，对于未来全球肝癌诊疗规范化的影响具有更高的指导意义。

Abstract:

In April 2024, the "Guidelines for the diagnosis and treatment of primary liver cancer (2024 edition)" were officially released. The guidelines were developed by experts and scholars from various disciplines in the field of liver cancer across the country under the leadership of the Department of Medical Administration of the National Health Commission of the People's Republic of China and with guidance from the Expert Committee on the Compilation of Guidelines for the Diagnosis and Treatment of Primary Liver Cancer, the National Cancer Center, and the Liver Cancer Quality Control Expert Committee of the National Cancer Quality Control Center. The main updates in the "Guidelines for the diagnosis and treatment of primary liver cancer (2024 edition)" include: updates to surgical treatment methods and concepts; objective evaluation of the value of local ablation; revitalization of vascular intervention therapy; further exploration and optimization of radiotherapy; and significant breakthroughs in systemic treatment. As a normative guidance document for primary liver cancer, the guidelines keep pace with the times, timely reflecting new developments and concepts in the field of liver cancer diagnosis and treatment, which will effectively drive the elevation of standardized diagnosis and treatment levels for liver cancer in China, enhanced the influence of our country in this field within the academic community, and hold high guiding significance for the future global standardization of liver cancer diagnosis and treatment.